Lascco
Company Team Projects Media Contact

 

Investing in biomedical discoveries

LASCCO SA is a biomedical-technology development private company based in Geneva, Switzerland. The primary objective of LASCCO is to bring promising early-stage biomedical technologies – therapeutics and diagnostics – developed in research institutes to the attention of the pharmaceutical industry.

 

 

LATEST NEWS:

LASCCO and Sepstone Diagnostics announce important milestone reached by Abionic in the development of the rapid PSP test for sepsis - 12/10/2016

Combioxin SA escalates to high dose in CAL02-001 trial in patients with severe pneumococcal pneumonia following IDMC's positive recommendation- 09/08/2016

Lascco